Richard Heuer, MD
Thoracic Surgery · Somerset, KYNPI 1497757439
Payments from drug & device makers
Across 191 payments — averaging $51.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$3K
- Silk Road Medical, Inc.$2K
- Edwards Lifesciences$860
- Medtronic$723
- Corcym Inc$454
- Dutch Ophthalmic, USA$375
- plus $3K from 31 others
What the payments were for
- Speaking & faculty fees$3754%
- Travel & lodging$1,42415%
- Food & beverage$7,97082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 20 | $2,720 |
| Silk Road Medical, Inc. | 10 | $1,520 |
| Edwards Lifesciences | 26 | $860 |
| Medtronic(2 entities) | 20 | $723 |
| Corcym Inc | 8 | $454 |
| Dutch Ophthalmic, USA | 1 | $375 |
| Atricure, Inc. | 16 | $368 |
| Penumbra, Inc. | 3 | $338 |
| Johnson & Johnson(2 entities) | 14 | $326 |
| Bard Peripheral Vascular, Inc. | 11 | $266 |
| Saphena Medical, Inc. | 2 | $221 |
| Angiodynamics, Inc. | 7 | $218 |
| Boston Scientific | 4 | $151 |
| Abbott | 6 | $142 |
| Terumo Cardiovascular Systems Corporation | 3 | $127 |
| La Jolla Pharmaceutical Company | 1 | $127 |
| AstraZeneca | 2 | $122 |
| Getinge USA Sales, LLC | 2 | $109 |
| Livanova USA, Inc. | 5 | $72 |
| Abiomed | 3 | $67 |
| W. L. Gore & Associates, Inc. | 1 | $60 |
| Shockwave Medical, Inc | 1 | $54 |
| Zimmer Biomet | 3 | $46 |
| Baxter Healthcare | 3 | $40 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $32 |
| Merck | 2 | $30 |
| Kls-martin L.p. | 3 | $25 |
| Intuitive Surgical | 1 | $25 |
| Amgen | 2 | $25 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Artivion, Inc. | 2 | $20 |
| Cagent Vascular Inc | 1 | $17 |
| Avanos Medical | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Imperative Care, Inc | 1 | $13 |
| Covidien LP | 1 | $11 |
| Cardiovascular Systems Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$1,316
- ENROUTE Transcarotid Stent$1,316
- Ovation$1,134
- Alto Abdominal Stent Graft System$743
- AFX$605
- EVA Ophthalmic Surgical System$375
- Indigo$323
- Perceval$215
- Torus Stent Graft System$174
- ENDOCROSS Device$174
- ALTO$159
- Venapax$138
- GIAPREZA$127
- ENDURANT IIS$118
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$114
- Ovation iX Iliac Stent Graft$110
- COREVALVE EVOLUT R$107
- FARXIGA$103
How this compares
Too few thoracic surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 30 | $853 |
| ClopidogrelClopidogrel Bisulfate | 14 | $191 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.